Prelude Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Prelude Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Prelude Therapeutics Inc
Rating: 1.91891675
Author: Trendlyne DVM scores

about

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinica...

4.48 0.01 (0.22%)

497.33% Gain from 52W Low

472.2K

XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.7 / 100

Technically Bullish

71.6 / 100

1Yr Price target upside is 84%

4 analysts

Prelude Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Prelude Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinica...

497.33% Gain from 52W Low

SWOT Analysis

Prelude Therapeutics Inc Live Price Chart